SynthesisWorld journal of surgical oncology2016

The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients' survival: a meta-analysis.

Hailong Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.